Article info
PDFCritical care
Original article
Novel anti-tumour necrosis factor receptor-1 (TNFR1) domain antibody prevents pulmonary inflammation in experimental acute lung injury
- Correspondence to Dr Daniel Francis McAuley, Centre for Experimental Medicine, Queen’s University of Belfast, Belfast, BT9 7AE, UK; d.f.mcauley{at}qub.ac.uk
Citation
Novel anti-tumour necrosis factor receptor-1 (TNFR1) domain antibody prevents pulmonary inflammation in experimental acute lung injury
Publication history
- Received March 23, 2017
- Revised November 20, 2017
- Accepted December 11, 2017
- First published January 29, 2018.
Online issue publication
September 01, 2022
Article Versions
- Previous version (29 July 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/